TP53 and breast carcinoma: The HER2 breast cancer subtype was characterized by the frequent amplifications of the HER2 gene (about 80% of cases), frequent TP53 mutations (about 72%) and PIK3CA mutations (39%), and a lower frequency of PIK3R1 (about 4%).